-
Something wrong with this record ?
Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE
N. Gaspar, LV. Marshall, D. Binner, R. Herold, R. Rousseau, P. Blanc, R. Capdeville, J. Carleer, C. Copland, Y. Kerloeguen, K. Norga, L. Pacaud, MA. Sevaux, C. Spadoni, J. Sterba, F. Ligas, T. Taube, M. Uttenreuther-Fischer, S. Chioato, MA....
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NV16-34083A
MZ0
CEP Register
NV16-34083A
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
NLK
Free Medical Journals
from 1996 to 1 year ago
PubMed
29351570
DOI
10.1093/annonc/mdy002
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Clinical Trials as Topic * MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Neoplasms drug therapy MeSH
- Antineoplastic Agents therapeutic use MeSH
- Drug Development * MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Belgium Federal Agency for Medicines and Health Products EUROSTATION Brussels Belgium
Boehringer Ingelheim Pharma GmbH and Co KG TA Oncology Biberach Germany
Centre for English Language Teaching University of York York UK
Centre Léon Bérard and University Claude Bernard Lyon 1 Lyon
Create for Chloe and UK Representative for aPODD European Medicines Agency London UK
Department of Oncology for Children and Adolescents Gustave Roussy Cancer Campus Villejuif France
Drug Development Department Gustave Roussy Villejuif and University Paris Sud Orsay France
Gritstone Oncology Inc Emeryville USA
Imagine for Margo Fourqueux France
Jeunes Solidarité Cancer Paris France
Pharmaceuticals Division PDOA Oncology F Hoffmann La Roche Ltd Basel Switzerland
PODD Foundation City Point London UK
Product Development Scientific Support Department European Medicines Agency London UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028610
- 003
- CZ-PrNML
- 005
- 20190816105559.0
- 007
- ta
- 008
- 190813s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/annonc/mdy002 $2 doi
- 035 __
- $a (PubMed)29351570
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Gaspar, N $u Department of Oncology for Children and Adolescents, Gustave Roussy Cancer Campus, Villejuif, France.
- 245 10
- $a Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE / $c N. Gaspar, LV. Marshall, D. Binner, R. Herold, R. Rousseau, P. Blanc, R. Capdeville, J. Carleer, C. Copland, Y. Kerloeguen, K. Norga, L. Pacaud, MA. Sevaux, C. Spadoni, J. Sterba, F. Ligas, T. Taube, M. Uttenreuther-Fischer, S. Chioato, MA. O'Connell, B. Geoerger, JY. Blay, JC. Soria, S. Kaye, B. Wulff, L. Brugières, G. Vassal, ADJ. Pearson, Members of Working Group 1 of the Paediatric Platform of ACCELERATE,
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a protinádorové látky $x terapeutické užití $7 D000970
- 650 12
- $a klinické zkoušky jako téma $7 D002986
- 650 12
- $a vyvíjení léků $7 D000076722
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nádory $x farmakoterapie $7 D009369
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Marshall, L V $u Paediatric and Adolescent Drug Development Team, Oak Centre for Children & Young People, The Royal Marsden Hospital & The Institute of Cancer Research, London, UK.
- 700 1_
- $a Binner, D $u Create for Chloe and UK Representative for aPODD, European Medicines Agency, London, UK.
- 700 1_
- $a Herold, R $u Product Development Scientific Support Department, European Medicines Agency, London, UK.
- 700 1_
- $a Rousseau, R $u Gritstone Oncology, Inc., Emeryville, USA.
- 700 1_
- $a Blanc, P $u Imagine for Margo, Fourqueux, France.
- 700 1_
- $a Capdeville, R $u Novartis AG, Basel, Switzerland.
- 700 1_
- $a Carleer, J $u Belgium Federal Agency for Medicines and Health Products, EUROSTATION, Brussels, Belgium.
- 700 1_
- $a Copland, C $u Centre for English Language Teaching, University of York, York, UK.
- 700 1_
- $a Kerloeguen, Y $u Pharmaceuticals Division, PDOA, Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
- 700 1_
- $a Norga, K $u Belgium Federal Agency for Medicines and Health Products, EUROSTATION, Brussels, Belgium. Universitair Ziekenhuis Antwerpen, Edegem, Belgium.
- 700 1_
- $a Pacaud, L $u Novartis AG, Basel, Switzerland.
- 700 1_
- $a Sevaux, M-A $u Jeunes Solidarité Cancer, Paris, France.
- 700 1_
- $a Spadoni, C $u aPODD Foundation, City Point, London, UK.
- 700 1_
- $a Sterba, J $u Pediatric Oncology Department, University Hospital Brno, School of Medicine Masaryk University Brno, Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, ICRC Brno, St. Anna University Hospital Brno, Czech Republic.
- 700 1_
- $a Ligas, F $u Product Development Scientific Support Department, European Medicines Agency, London, UK.
- 700 1_
- $a Taube, T $u Boehringer Ingelheim, Pharma GmbH&Co KG, TA Oncology, Biberach, Germany.
- 700 1_
- $a Uttenreuther-Fischer, M $u Boehringer Ingelheim, Pharma GmbH&Co KG, TA Oncology, Biberach, Germany.
- 700 1_
- $a Chioato, S $u Regulatory Strategy Oncology, Pfizer Italia, Milano, Italy.
- 700 1_
- $a O'Connell, M A $u Regulatory Strategy Oncology, Pfizer Italia, Milano, Italy.
- 700 1_
- $a Geoerger, B $u Department of Oncology for Children and Adolescents, Gustave Roussy Cancer Campus, Villejuif, France.
- 700 1_
- $a Blay, J-Y $u Centre Léon Bérard and University Claude Bernard Lyon 1, Lyon.
- 700 1_
- $a Soria, J C $u Drug Development Department (DITEP), Gustave Roussy, Villejuif and University Paris-Sud, Orsay, France.
- 700 1_
- $a Kaye, S $u Adult Drug Development Unit, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK.
- 700 1_
- $a Wulff, B $u Paediatric Haematology/Oncology, Clinical Research/Paediatric Drug Development, University Childrens Hospital III Hufelandstraße, Essen, Germany.
- 700 1_
- $a Brugières, L $u Department of Oncology for Children and Adolescents, Gustave Roussy Cancer Campus, Villejuif, France.
- 700 1_
- $a Vassal, G $u Department of Clinical Research, Gustave Roussy, Villejuif and Paris-Sud University, Le Kremlin-Bicêtre, France.
- 700 1_
- $a Pearson, A D J $u Paediatric and Adolescent Drug Development Team, Oak Centre for Children & Young People, The Royal Marsden Hospital & The Institute of Cancer Research, London, UK.
- 710 2_
- $a Members of Working Group 1 of the Paediatric Platform of ACCELERATE
- 773 0_
- $w MED00000432 $t Annals of oncology : official journal of the European Society for Medical Oncology $x 1569-8041 $g Roč. 29, č. 3 (2018), s. 766-771
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29351570 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190816105828 $b ABA008
- 999 __
- $a ok $b bmc $g 1433759 $s 1067070
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 29 $c 3 $d 766-771 $e 20180301 $i 1569-8041 $m Annals of oncology $n Ann Oncol $x MED00000432
- GRA __
- $a NV16-33209A $a NV16-34083A $p MZ0 $p MZ0
- GRA __
- $a NV16-33209A $a NV16-34083A $p MZ0 $p MZ0
- LZP __
- $a Pubmed-20190813
